IONIS PHARMACEUT reported $521.92M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Astellas Pharma 4503:JP Y 313013M 2973M
Biocryst Pharmaceuticals BCRX:US $ 417.48M 21.98M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Esperion Therapeutics ESPR:US $ 122.94M 27.42M
Exelixis EXEL:US $ 627M 96.27M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novartis NOVN:VX SF 3625M 10227M
Omeros OMER:US $ 14.14M 5.17M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M